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Abstract
Background: Women diagnosed with breast cancer frequently attribute their cancer to psychological stress, but
scientific evidence is inconclusive. We investigated whether experienced frequency of stress and adverse life events
affect subsequent breast cancer risk.
Methods: Breast cancer incidence was analysed with respect to stress variables collected at enrolment in a
prospective cohort study of 106,000 women in the United Kingdom, with 1783 incident breast cancer cases.
Relative risks (RR) were obtained as hazard ratios using Cox proportional hazards models.
Results: There was no association of breast cancer risk overall with experienced frequency of stress. Risk was
reduced for death of a close relative during the 5 years preceding study entry (RR = 0.87, 95 % confidence interval
(CI): 0.78–0.97), but not for death of a spouse/partner or close friend, personal illness/injury, or divorce/separation.
There was a positive association of divorce with oestrogen-receptor-negative (RR = 1.54, 95 % CI: 1.01–2.34), but not
with oestrogen-receptor-positive breast cancer. Risk was raised in women who were under age 20 at the death of
their mother (RR = 1.31, 95 % CI: 1.02–1.67), but not of their father, and the effect was attenuated after excluding
mothers with breast or ovarian cancer (RR = 1.17, 95 % CI: 0.85–1.61).
Conclusions: This large prospective study did not show consistent evidence for an association of breast cancer risk
with perceived stress levels or adverse life events in the preceding 5 years, or loss of parents during childhood and
adolescence.
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Background
Breast cancer is the most commonly diagnosed cancer
among females in the Western world, and its aetiology
entails a multitude of genetic, reproductive, hormonal,
and exogenous factors. Women with breast cancer fre-
quently attribute the origin of their breast cancer, how-
ever, to psychological factors such as stress [1] although
scientific evidence for this is inconclusive.
Stress has been defined theoretically as the response of
the body to the presence of external demands or, more
subjectively, as the response to the individual’s appraisal
of demands depending on their coping abilities [2, 3].
Proposed biological mechanisms for an effect of stress
on cancer development include neuroendocrine alter-
ations in the hypothalamus-pituitary-adrenal axis regu-
lating glucocorticoid release and the sympathetic
nervous system regulating catecholamine levels [4, 5].
Overactivation of the allostatic system is thought pos-
sibly to impair immune response [6] and release of stress
hormones has been implicated in DNA repair, tumour
cell growth and angiogenesis [7–10]. However, a
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protective effect of stress on breast cancer risk through
suppression of oestrogen secretion has also been pro-
posed [11–13]. Indirect effects of stress on health and
cancer risk, through changes in lifestyle and behaviour,
are also possible, and stress may render women more
susceptible to progression or recurrence of cancer ei-
ther by affecting recovery or compliance with their
treatment.
Past epidemiological studies of exposure to psycho-
logical stress and breast cancer risk have predominantly
reported breast cancer risk after adverse life events such
as bereavement or divorce, as these are relatively easily
ascertained, objective measures of major external
stressors [14]. Only a few studies have investigated more
subjective measures such as perceived experience of
stress, which could reflect a subject’s coping in response
to stressors. Some have investigated risk in women who
were bereaved of their parents during childhood, as the
impact of psychological stress might be particularly great
during this period of development. Past studies of psy-
chological stress, however, have mainly been case-
control or cohort studies with small numbers of cases,
or record-linkage-based studies that have had no or lim-
ited ability to adjust for confounding variables. They
have been methodologically diverse in design, adjust-
ment for confounders, population characteristics and the
type of effect measures investigated, and appear to have
been subject to publication bias [15]. The studies’ het-
erogeneous results have been reflected in the contradict-
ory conclusions of reviews [12, 15–18].
To address this issue, large prospective cohort studies
are needed because such studies have the substantial
advantage over those of retrospective design in that
recall bias is avoided. We therefore investigated per-
ceived frequency of stress, experience of adverse life
events and bereavement at young ages in relation to
breast cancer risk in a large prospective cohort study
in the United Kingdom.
Methods
The Breakthrough Generations Study is a cohort study
of over 113,000 women in the UK, aged 16 or older, fo-
cused on breast cancer aetiology. The main recruitment
phase was during 2003–2010, with baseline recruitment
involving a postal questionnaire about established and
candidate breast cancer risk factors, and donation of a
blood sample. Participants are followed up approxi-
mately every 2.5–3 years by postal questionnaires, to
obtain updated risk factor information as well as details
of breast cancer diagnoses. Full details of the cohort
methods have been published previously [19].
Notification of incident cancers is obtained from
follow-up questionnaires and ‘flagging’ at the National
Health Service Central Registers (NHSCR), virtually
complete registers of the population of the country,
which notify cancer registrations in subjects ‘flagged’ for
the study to authorised medical researchers as well as in-
formation on emigrations and deaths. Confirmation of
self-reported diagnoses is obtained from the cancer reg-
istrations, participants’ general practitioners, pathology
reports and other hospital records.
The current analysis is based on all women who joined
the Breakthrough Generations Study before 1 July 2012
without previous breast cancer, the recruitment cut-off
date reflecting the date by which the first follow-up for
the questionnaire was practically complete. Follow-up
for breast cancer started at the date of receipt of the
recruitment questionnaire and ended on the date of
mailing for follow-up questionnaires, or if the follow-up
questionnaire was not returned and the woman was cov-
ered by ‘flagging’ the earliest of the date the individual’s
‘flagging’, coverage ended (i.e. at death or removal from
the NHSCR), or the date after which ‘flagging’ notifica-
tion is not yet complete (taken to be 1 March 2014). If
the follow-up questionnaire was not returned and the
woman was not covered by ‘flagging’, the follow-up was
truncated at the date of her previous questionnaire.
Data on stress variables were obtained from the
baseline questionnaire, which asked whether subjects
felt they had been experiencing stress over the last
5 years, to which they were invited to respond ‘never’,
‘occasionally’, ‘frequently’ or ‘continuously’. We com-
bined the ‘never’ and ‘occasionally’ categories in the
analyses due to the low number of subjects who re-
ported ‘never’. The questionnaire also asked whether
in the last 5 years they had experienced: death of a
husband or long-term partner; death of a child, par-
ent or other close relative; death of a close friend; di-
vorce or separation; serious personal illness or injury;
loss of a job; or another life event that they found
very stressful. The pilot version of the baseline ques-
tionnaire did not include these questions and there-
fore the pilot subjects (n = 5387) were excluded from
analyses of adverse life events. For analyses of age at
death of parents, dates of death of parents were ob-
tained from information in the questionnaire about
first-degree relatives and were used to compute the
subject’s age at bereavement.
Statistical analysis
Relative risks (RR) with 95 % confidence intervals (CI)
for breast cancer were obtained as hazard ratios using
Cox proportional hazards models fitted in Stata 14.1
[20] with attained age as the underlying time variable,
invasive or in situ breast cancer diagnosis as the event of
interest, and censoring at diagnosis, death or end of
follow-up, whichever was earliest. Results were adjusted
for known breast cancer risk factors that were associated
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with the stress variables analysed in our data set: age at
menarche, age at first birth and parity, cumulative dur-
ation of breast feeding, body mass index (BMI) at age
20, postmenopausal BMI and time-updated menopausal
status, adult height, oral contraceptive use and postmen-
opausal combined (oestrogen and progestogen) hormone
use, history of benign breast disease, physical activity (in
metabolic equivalents, METs, hours/week), alcohol con-
sumption, cigarette smoking, family history of breast
cancer and socio-economic status. The latter was based
on place of residence (Acorn scores [21]). We also ex-
amined hazard ratios adjusted for age only, to assess the
likelihood that the results were ‘overmatched’ on lifestyle
factors. Results for the two models were similar for most
risk factors. Therefore, multivariate-adjusted relative
risks are reported throughout and age-adjusted relative
risks only where they were materially different. All re-
ported P values are two-sided.
We repeated the analyses for premenopausal and
postmenopausal women separately, and by oestrogen-
receptor status and extent (invasive/in situ) of breast
cancer.
Results
During 2003–2012 a recruitment questionnaire was
completed by 106,612 women without a history of breast
cancer (Table 1). Follow-up was through to the sched-
uled completed follow-up questionnaire for 94.6 % of
these women. Of the remainder, 1.7 % had developed
breast cancer, 0.7 % had died by this time, 2.6 % were
alive and had not completed the questionnaire but their
vital and cancer status was available from NHSCR, and
0.4 % were lost to follow-up at an earlier date or no
follow-up was available. The follow-up rate (calculated
as the total observed person-years divided by the max-
imum person-years that would theoretically have been
achievable if there were no loss to follow-up (except
breast cancer and deaths)) was 99.5 %, over an average
follow-up period of 6.1 years. There were 1783 women
who had developed a first invasive (n = 1510) or in situ
breast cancer (n = 273), for whom oestrogen-receptor
status was known for 92.9 % (99.3 % of invasive, 57.5 %
of in situ).
Thirty-four percent of women reported frequent or
continuous stress and 74 % at least one adverse life
event over the preceding 5 years, ranging from 2.5 % for
widowhood to 46.7 % for ‘other life event that they
found very stressful’. Women reporting frequent or con-
tinuous stress were more likely to have had an adverse
life event. Regarding bereavement of parents, 2.5 % of
women had lost their mother and 5.1 % their father
when they were under 20 years of age. Each of these
stress variables was associated with risk factors for breast
cancer (Additional file 1: Tables S1–S3).
Relative risks for breast cancer overall in relation to fre-
quency of stress or adverse life events during the 5 years
preceding entry to the study ranged between 0.9 and 1.2
and were not statistically significant with the exception of
an inverse association with death of a close relative other
than a spouse or partner (RR = 0.87, 95 % confidence
interval (CI): 0.78–0.97) (Table 2). Relative risks for
oestrogen-receptor-positive breast cancer were similar to
those for all breast cancers combined. For oestrogen-
Table 1 Baseline characteristics of study participants in the
Breakthrough Generations Study recruited 2003–2012
Characteristic Mean or No. SD or %
Age at recruitment, years 46.6 13.5




Status not known 5216 5.0
Never had periods 34 0.0
First-degree family history of breast cancer
No 90,061 84.5
Yes 16,551 15.5
Age at first full-term pregnancy, years
≤24 25,982 24.4
25 to 34 46,690 43.8
≥35 4365 4.1
Parous, unknown age 166 0.2
Nulliparous 29,244 27.4




Socio-economic status based on place of residence




5 (lowest) 6109 5.7






Other or not known 499 0.4
Total 106,612 100.0
a507 because they were resident in the Channel Islands, 315 for other reasons
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Table 2 Relative risk of breast cancer in relation to experience of stress and adverse life events during the 5 years preceding entry
to the study, Breakthrough Generations Study
Oestrogen-receptor status of breast cancer
All cases Positive Negative
Factor No. of cases Adjusted RR
(95 % CI)b
No. of cases Adjusted RR
(95 % CI)b
No. of cases Adjusted RR
(95 % CI)b
Frequency of experience of stressa
Never/occasionally 1112 1.00 871 1.00 161 1.00
Frequently 460 0.92 (0.83–1.03) 355 0.91 (0.81–1.04) 74 1.01 (0.77–1.34)
Continuously 86 0.92 (0.73–1.15) 70 0.96 (0.75–1.23) 9 0.70 (0.36–1.38)
P trend = 0.15 P trend = 0.26 P trend = 0.55
Adverse life eventsb:
Death of husband/partner
No 1606 1.00 1255 1.00 236 1.00
Yes 64 1.13 (0.88–1.46) 48 1.07 (0.80–1.44) 11 1.52 (0.82–2.82)
Death of child/parent or other close relative
No 1200 1.00 933 1.00 185 1.00
Yes 470 0.87 (0.78–0.97) 370 0.88 (0.78–0.99) 62 0.76 (0.57–1.02)
Death of close friend
No 1390 1.00 1088 1.00 201 1.00
Yes 280 0.94 (0.83–1.08) 215 0.91 (0.79–1.05) 46 1.16 (0.84–1.61)
Personal illness/injury
No 1520 1.00 1189 1.00 221 1.00
Yes 150 1.03 (0.87–1.22) 114 0.99 (0.82–1.21) 26 1.28 (0.85–1.93)
Loss of job
No 1534 1.00 1196 1.00 230 1.00
Yes 136 1.09 (0.91–1.30) 107 1.09 (0.89–1.33) 17 0.94 (0.57–1.54)
Divorce/separation
No 1541 1.00 1207 1.00 222 1.00
Yes 129 1.15 (0.96–1.38) 96 1.09 (0.89–1.33) 25 1.54 (1.01–2.34)
Other stressful life event
No 929 1.00 745 1.00 124 1.00
Yes 741 0.95 (0.86–1.05) 558 0.90 (0.80–1.00) 123 1.17 (0.91–1.51)
Any of the above
No 425 1.00 339 1.00 57 1.00
Yes 1245 0.95 (0.85–1.06) 964 0.92 (0.81–1.04) 190 1.12 (0.83–1.52)
Number of events
0 425 1.00 339 1.00 57 1.00
1 714 0.97 (0.86–1.09) 560 0.95 (0.83–1.09) 107 1.10 (0.80–1.53)
2 373 0.93 (0.81–1.07) 285 0.88 (0.75–1.03) 54 1.07 (0.73–1.55)
≥3 158 0.93 (0.77–1.12) 119 0.87 (0.70–1.07) 29 1.37 (0.87–2.16)
P trend = 0.25 P trend = 0.050 P trend = 0.25
RR relative risk, CI confidence interval
aBased on 101,225 subjects
bAnalyses adjusted for attained age, age at menarche, age at first birth and parity, cumulative duration of breast feeding, oral contraceptive use, postmenopausal
hormone use, benign breast disease, BMI at age 20, postmenopausal BMI and time-updated menopausal status, height, physical activity, alcohol consumption,
cigarette smoking, family history of breast cancer and socio-economic status
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receptor-negative breast cancer, risk was borderline sig-
nificantly raised after divorce or separation (RR = 1.54,
95 % CI: 1.01–2.34) and non-significantly reduced after
death of a close relative (RR = 0.76, 95 % CI: 0.57–1.02),
with analyses for other factors not showing associations.
Breast cancer risk was not associated with death of a
mother or father overall but was significantly raised (age-
adjusted RR = 1.55, 95 % CI: 1.22–1.96; multivariate-
adjusted RR = 1.31, 95 % CI: 1.02–1.67) in women who
were aged less than 20 years at the time of loss of their
mother, but not their father (Table 3). In analyses re-
stricted to the 92,441 women whose mother had not
had breast or ovarian cancer, this association was at-
tenuated (RR = 1.17, 95 % CI: 0.85–1.61). Relative
risks were higher for oestrogen-receptor-negative
breast cancer, based on 13 cases, than for oestrogen-
receptor-positive breast cancer.
In secondary analyses, results of stress experience for
invasive and in situ (n = 1510 and n = 273) and premeno-
pausal and postmenopausal breast cancer separately
(n = 1248 and n = 535, respectively) were similar, except
for frequent stress, for which a reduced breast cancer risk
was observed among postmenopausal (RR = 0.82, 95 % CI:
0.72–0.94) but not premenopausal (RR = 1.18, 95 % CI:
0.97–1.42) women. No association was observed, however,
with continuous stress (RR = 0.96, 95 % CI: 0.74–1.25 for
postmenopausal and RR = 0.78, 95 % CI: 0.50–1.24 for
premenopausal women). With respect to divorce, relative
risks were greater for premenopausal (RR = 1.26, 95 % CI:
0.96–1.65) than for postmenopausal (1.04, 95 % CI: 0.81–
1.34) women, but neither were statistically significant.
Risk in women who were aged 20 and under at loss
of their mother was greater among premenopausal
(RR = 1.63, 95 % CI: 1.06–2.51 attenuated to 1.36,
95 % CI: 0.67–2.75 after excluding mothers with breast or
ovarian cancer) than postmenopausal (RR = 1.18, 95 % CI:
0.88–1.59 and RR = 1.13, 95 % CI: 0.79–1.62, respectively)
women. Relative risks for all mothers were greater for
in situ (HR = 1.68, 95 % CI: 0.98–2.90) than invasive
(RR = 1.24, 95 % CI: 0.94–1.63) breast cancer. The as-
sociation for in situ breast cancer was not attenuated
after excluding mothers with breast or ovarian cancer
(RR = 1.88, 95 % CI: 0.97–3.64), based on ten cases.
Discussion
Our study has the strengths that it is of prospective design,
has a large number of cases with highly complete cohort
follow-up, includes a wide range of stress variables and has
information enabling analyses by oestrogen-receptor sta-
tus. In addition, we were able to investigate the effect of
adjustment for breast cancer risk factors on relative risk es-
timates, which is advantageous because the stress variables
were associated with behavioural factors such as exercise,
smoking, alcohol consumption and obesity.
Women who reported frequent or continuous stress
had a comparable risk of breast cancer to those who
never or occasionally experienced stress. Our study was
fourfold larger than previous studies on this topic, with
the exception of the Nurses’ Health Study of care-giving
stress, which had a similar number of cases and reported
a protective effect for some but not all measures of
stress [11]. A lack of association is consistent with the
results in two other cohorts [22, 23], but not with three
others: one reporting a significant protective effect of
self-reported stress [24], and two increased risks in
women with raised stress levels [25, 26]. Reasons for
these disparities are unclear, but methodological differ-
ences in the definition of stress might have contributed.
In a recent study of women followed through two men-
strual cycles, those who reported high daily stress
experience had lower oestradiol levels than those who
reported no or little stress [13]. Our study, however, did
not observe an inverse association of breast cancer risk
with perceived stress in premenopausal women.
Breast cancer risk in our study was not associated with
having had any adverse life event during the 5 years pre-
ceding entry to the study, or with the total number of
such events, a finding supported by previous investiga-
tions by the Women’s Health Initiative [27] and the
European Prospective Investigation into Cancer [23], but
contrasting with several case-control studies [28–31].
We observed, however, a protective effect in those who
had lost a close relative other than a spouse/partner, a
finding which was weakly supported by that of death of
a close friend, but not by the null association with re-
spect to death of a spouse/partner. In the Holmes-Rahe
Social Readjustment Rating Scale [14], death of a spouse
and divorce receive the highest scores, with death of a
close family member being rated fifth. Therefore, given
the absence of an association with death of a spouse, the
finding for loss of a close relative might be a chance
finding. A lack of association with loss of a relative
would be consistent with Scandinavian record-linkage
studies [32–36], but not with a Finnish prospective study
of 10,800 women showing increased risks of breast can-
cer after death of a spouse, a close relative or friend [37],
or with a case-control study showing an increased risk
after loss of a close relative [31]. Explanations for the
heterogeneity in these findings are unclear but poten-
tially include chance, lack of adjustment for confounders
and differences in the timing of the stressor.
We did not observe an association with divorce, except
for a positive association for oestrogen-receptor-negative
breast cancer only. No previous studies reported on as-
sociations by receptor status, and given that we are the
first to report this association, it should be investigated
by other studies. Our results hinted that the association
might be restricted to premenopausal women only,
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which would be consistent as premenopausal women are
more likely than postmenopausal women to have
oestrogen-receptor-negative breast cancer [38]. A twofold
increased risk of breast cancer overall after divorce has
been previously reported by a prospective study [37], but a
record-linkage study [32] reported a significant 20 %
Table 3 Relative risk of breast cancer in relation to participant’s age at death of parent, Breakthrough Generations Study
Oestrogen receptor status of breast cancer
All cases Positive Negative
Factor No. of cases Adjusted RR
(95% CI)(a)
No. of Cases Adjusted RR
(95% CI)(a)




No 916 1.00 700 1.00 146 1.00
Yes 867 0.99 (0.89-1.10) 690 1.00 (0.89-1.13) 121 0.96 (0.72-1.27)
Age of participant at mother’s
death, years
<20 75 1.31 (1.02-1.67) 55 1.21 (0.89-1.61) 13 1.67 (0.93-2.98)
20-29 91 1.02 (0.82-1.27) 72 1.04 (0.81-1.33) 13 1.01 (0.57-1.80)
30-39 178 1.07 (0.91-1.27) 135 1.04 (0.86-1.26) 26 1.09 (0.71-1.68)
40-49 221 0.88 (0.75-1.03) 187 0.95 (0.80-1.13) 23 0.62 (0.39-0.99)
≥50 302 0.94 (0.81-1.10) 241 0.96 (0.81-1.14) 46 1.01 (0.68-1.49)
P trend=0.059 P trend=0.22 P trend=0.46
Mothers who did not have breast
or ovarian cancer
Mother deceased
No 790 1.00 603 1.00 128 1.00
Yes 633 0.94 (0.83-1.07) 507 0.98 (0.85-1.13) 88 0.82 (0.60-1.13)
Age of participant at mother’s
death, years
<20 41 1.17 (0.85-1.61) 29 1.05 (0.72-1.55) 7 1.35 (0.62-2.92)
20-29 54 1.04 (0.78-1.38) 43 1.07 (0.78-1.47) 7 0.86 (0.40-1.86)
30-39 119 1.05 (0.86-1.29) 92 1.05 (0.84-1.32) 16 0.92 (0.54-1.57)
40-49 173 0.86 (0.72-1.03) 150 0.98 (0.80-1.19) 16 0.50 (0.28-0.87)
≥50 246 0.89 (0.75-1.05) 193 0.90 (0.75-1.09) 42 0.98 (0.65-1.49)
P trend=0.046 P trend=0.19 P trend=0.86
All fathers
Father deceased
No 730 1.00 568 1.00 104 1.00
Yes 1053 0.95 (0.85-1.06) 822 0.92 (0.81-1.04) 163 1.23 (0.92-1.65)
Age of participant at father’s
death, years
<20 105 0.94 (0.76-1.16) 80 0.88 (0.69-1.12) 18 1.37 (0.82-2.30)
20-29 163 0.96 (0.81-1.15) 133 0.98 (0.80-1.19) 22 1.12 (0.69-1.80)
30-39 259 0.92 (0.79-1.06) 205 0.90 (0.76-1.07) 37 1.08 (0.72-1.61)
40-49 326 1.00 (0.87-1.16) 257 0.98 (0.83-1.15) 49 1.30 (0.89-1.90)
≥50 200 0.91 (0.77-1.09) 147 0.82 (0.67-1.00) 37 1.50 (0.97-2.31)
P trend=0.97 P trend=0.56 P trend=0.40
RR relative risk, CI confidence interval
(a) Analyses adjusted for attained age, age at menarche, age at first birth and parity, cumulative duration of breast feeding, oral contraceptive use,
postmenopausal hormone use, benign breast disease, BMI at age 20, postmenopausal BMI and time-updated menopausal status, height, physical activity, alcohol
consumption, cigarette smoking, family history of breast cancer and socioeconomic status
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reduced risk of breast cancer among divorced compared
with married women, with no or weak associations re-
ported by case-control studies [29, 39].
Bereavement during childhood and adolescence has a
well-established long-term impact on both mental and
physical health [5, 40–42] and it is possible that it affects
subsequent breast cancer risk. A direct role of cortisol
on breast tissue development and oestrogen production
and activity has been proposed as a potential mechanism
[9], but changes in lifestyle subsequent to bereavement
and familial factors could also play a role. Breast cancer
risk after maternal death at young ages has not previ-
ously been investigated except for in two small prospect-
ive studies, one showing a 2.6-fold increased risk [43]
and the other reporting no association [44]. In our study,
having been bereaved under age 20 of a mother, but not
of a father, was associated with a significant increase in
breast cancer risk. This association was strongest for
premenopausal women and for oestrogen-receptor-
negative breast cancer. Women whose mother had
breast cancer at young ages are at increased risk of hav-
ing breast cancer at young ages themselves [45], and our
risk estimates were attenuated when analyses were re-
stricted to women whose mother did not have breast or
ovarian cancer. It appears, therefore, that the observed
associations are at least in part due to increased suscep-
tibility to breast cancer through genetic inheritance. The
stronger association for in situ than invasive cancer is
possibly due to enhanced breast cancer screening among
women who lost their mother early, but it is unclear
why this association appeared to be somewhat stronger
for women whose mother did not have breast or ovarian
cancer. This was based on a small number of cases,
however.
Limitations of our study are the lack of information on
the intensity of stress, on stress in the workplace, and on
the extent of social support or stress adaptive capacity,
although the latter measure was not associated with
breast cancer risk in a previous study [23]. Furthermore,
most of the analysed stress variables were collected for
the 5 years prior to completion of the baseline question-
naire only; we could not examine effects of such events
in earlier time windows. Our study did not collect informa-
tion on stressful events during childhood or adolescence
with the exception of loss of a parent. Future studies
should investigate stress and adverse events in such earlier
time windows, as well as focus on populations for which
our data were sparser, i.e. investigate effects of divorce and
other adverse events on breast cancer in young, premeno-
pausal women, by breast cancer characteristics.
Conclusions
In this large prospective study there was no consistent
evidence that self-reported frequency of stress and
experience of adverse life events affected subsequent
breast cancer risk. Raised risks in women who were be-
reaved of their mother during childhood or adolescence
were at least in part due to familial susceptibility.
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